Wikidata entity: Q176301
C₁₅H₁₂N₂O₂ (P274)
Quantities
| P4250 | defined daily dose | 1 |
| P2067 | mass | 252.09 |
| P3780 | active ingredient in | ... | Q47521955 (Oxtellar) | Oxtellar |
| P3780 | active ingredient in | ... | Q47522233 (Trileptal) | Trileptal |
| P233 | canonical SMILES | String | C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N | ??? |
| P373 | Commons category | String | Oxcarbazepine | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Oxcarbazepine%203d%20structure.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q188638 (mood disorder) | mood disorder |
| P2175 | medical condition treated | ... | Q41571 (epilepsy) | epilepsy |
| P2175 | medical condition treated | ... | Q1132120 (trigeminal neuralgia) | trigeminal neuralgia |
| P2175 | medical condition treated | ... | Q7140388 (focal epilepsy) | focal epilepsy |
| P129 | physically interacts with | ... | Q3459294 (Sodium voltage-gated channel alpha subunit 5) | Sodium voltage-gated channel alpha subunit 5 |
| P129 | physically interacts with | ... | Q6981557 (Sodium voltage-gated channel alpha subunit 4) | Sodium voltage-gated channel alpha subunit 4 |
| P129 | physically interacts with | ... | Q6981560 (Sodium voltage-gated channel alpha subunit 9) | Sodium voltage-gated channel alpha subunit 9 |
| P129 | physically interacts with | ... | Q6981561 (Sodium voltage-gated channel alpha subunit 11) | Sodium voltage-gated channel alpha subunit 11 |
| P129 | physically interacts with | ... | Q21126314 (sodium voltage-gated channel alpha subunit 1) | sodium voltage-gated channel alpha subunit 1 |
| P129 | physically interacts with | ... | Q21126334 (Sodium voltage-gated channel alpha subunit 10) | Sodium voltage-gated channel alpha subunit 10 |
| P129 | physically interacts with | ... | Q21135448 (Sodium voltage-gated channel alpha subunit 2) | Sodium voltage-gated channel alpha subunit 2 |
| P129 | physically interacts with | ... | Q21135449 (Sodium voltage-gated channel alpha subunit 3) | Sodium voltage-gated channel alpha subunit 3 |
| P3489 | pregnancy category | ... | Q28123617 (US pregnancy category C) | US pregnancy category C |
| P9989 | stylized name | String | OXcarbazepine | ??? |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q576618 (anticonvulsant agent) | anticonvulsant agent |
| P2868 | subject has role | ... | Q50430448 (voltage-gated sodium channel blockers) | voltage-gated sodium channel blockers |
| P2868 | subject has role | ... | Q50430523 (cytochrome P-450 CYP3A inducers) | cytochrome P-450 CYP3A inducers |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | oxcarbazepine | ??? |
| P267 | ATC code | N03AF02 |
| P231 | CAS Registry Number | 28721-07-5 |
| P683 | ChEBI ID | 7824 |
| P592 | ChEMBL ID | CHEMBL1068 |
| P661 | ChemSpider ID | 31608 |
| P9272 | DeCS ID | 57806 |
| P715 | DrugBank ID | DB00776 |
| P11198 | DrugCentral ID | 2017 |
| P8494 | DSSTOX compound identifier | DTXCID8025703 |
| P3117 | DSSTox substance ID | DTXSID0045703 |
| P232 | EC number | 249-188-8 |
| P2566 | ECHA Substance Infocard ID | 100.044.702 |
| P646 | Freebase ID | /m/025gxv |
| P595 | Guide to Pharmacology Ligand ID | 7254 |
| P2062 | HSDB ID | 7524 |
| P2057 | Human Metabolome Database ID | HMDB0014914 |
| P4168 | IEDB Epitope ID | 423615 |
| P234 | InChI | InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19) |
| P235 | InChIKey | CTRLABGOLIVAIY-UHFFFAOYSA-N |
| P665 | KEGG ID | D00533 |
| P665 | KEGG ID | C07492 |
| P6689 | MassBank accession ID | SM858353 |
| P10245 | MedlinePlus drug identifier | a601245 |
| P486 | MeSH descriptor ID | D000078330 |
| P672 | MeSH tree code | D03.633.300.240.127.500 |
| P6366 | Microsoft Academic ID (discontinued) | 2781176495 |
| P2115 | NDF-RT ID | N0000148642 |
| P2840 | NSC number | 758693 |
| P10283 | OpenAlex ID | C2781176495 |
| P4235 | PatientsLikeMe treatment ID | oxcarbazepine |
| P11199 | Probes And Drugs ID | PD001213 |
| P662 | PubChem CID | 34312 |
| P3345 | RxNorm CUI | 32624 |
| P4964 | SPLASH | splash10-0pb9-0090000000-46d01e1171f998679d03 |
| P2877 | SureChEMBL ID | 35129 |
| P4527 | UK Parliament thesaurus ID | 526334 |
| P2892 | UMLS CUI | C0069751 |
| P2892 | UMLS CUI | C0120125 |
| P11089 | UniChem compound ID | 286970 |
| P652 | UNII | VZI5B1W380 |
| P11143 | WikiProjectMed ID | Oxcarbazepine |
| P3350 | World Health Organisation international non-proprietary name numeric ID | 4585 |
Why not click here or view trends?
log id: 2182166